Aluria Advisory is a boutique healthcare M&A and operational advisory firm serving private equity firms, family offices, and behavioral health operators across the full deal lifecycle.
What sets the work apart is what informs it: licensed clinical practice, direct operator experience inside healthcare platforms, and hands-on involvement in live transactions. Most advisors bring one. We bring all three. That combination surfaces what standard financial diligence routinely misses: valuation mispricing, clinical integration risk, and post-close failures that are already embedded in the deal before it closes.
Our focus is behavioral health. That includes psychiatric outpatient, interventional psychiatry services including TMS and Spravato/esketamine, substance use disorder, and applied behavior analysis. We also advise on behavioral health services entering post-acute care settings including SNFs and ALFs, and on healthcare technology transactions evaluated both as acquisition targets and as components of behavioral health platform diligence.